Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-31 @ 1:18 AM
Study NCT ID:
NCT07415850
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-02-17
First Post:
2026-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2026-03-25'}, 'conditionBrowseModule': {'meshes': [{'id': 'D001008', 'term': 'Anxiety Disorders'}, {'id': 'D003863', 'term': 'Depression'}, {'id': 'D000092862', 'term': 'Psychological Well-Being'}, {'id': 'D006379', 'term': 'Helping Behavior'}], 'ancestors': [{'id': 'D001523', 'term': 'Mental Disorders'}, {'id': 'D001526', 'term': 'Behavioral Symptoms'}, {'id': 'D001519', 'term': 'Behavior'}, {'id': 'D010549', 'term': 'Personal Satisfaction'}, {'id': 'D012919', 'term': 'Social Behavior'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D015013', 'term': 'Yoga'}], 'ancestors': [{'id': 'D026441', 'term': 'Mind-Body Therapies'}, {'id': 'D000529', 'term': 'Complementary Therapies'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D026443', 'term': 'Spiritual Therapies'}, {'id': 'D026241', 'term': 'Exercise Movement Techniques'}, {'id': 'D026741', 'term': 'Physical Therapy Modalities'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'SUPPORTIVE_CARE', 'interventionModel': 'CROSSOVER', 'interventionModelDescription': 'This study uses a randomized controlled trial (RCT) design with a wait-list control group.'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 80}}, 'statusModule': {'overallStatus': 'NOT_YET_RECRUITING', 'startDateStruct': {'date': '2026-01-21', 'type': 'ESTIMATED'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2026-01', 'completionDateStruct': {'date': '2027-01-31', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2026-02-09', 'studyFirstSubmitDate': '2026-01-26', 'studyFirstSubmitQcDate': '2026-02-09', 'lastUpdatePostDateStruct': {'date': '2026-02-17', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2026-02-17', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-12-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Change from Baseline in Fertility Quality of Life using the FertiQoL, a validated 24-item self-report questionnaire, measured at 4 weeks and 8 weeks.', 'timeFrame': 'From enrollment (Baseline) to the end of treatment at 8 weeks.', 'description': 'The change in Fertility Quality of Life will be measured using the Fertility Quality of Life scale (FertiQoL), a validated 24-item self-report questionnaire that assesses fertility quality of life, with total scores ranging from 0 to 100. Higher scores mean higher quality of life.\n\nChange in FertiQoL will be measured between the intervention group and wait-list control group at baseline, 4 weeks, and 8 weeks.'}, {'measure': 'Change from Baseline in Anxiety symptom severity using the Hospital Anxiety and Depression Scale, Anxiety Subscale (HADS-A), measured at 4 weeks and 8 weeks.', 'timeFrame': 'From enrollment (Baseline) to the end of treatment at 8 weeks.', 'description': 'The change in Anxiety symptom severity will be measured using the Hospital Anxiety and Depression Scale, Anxiety Subscale (HADS-A), a validated 7-item questionnaire with scores ranging from 0 to 21, where higher scores indicate greater anxiety severity.\n\nChange in HADS-A will be measured between the intervention group and wait-list control group at baseline, 4 weeks, and 8 weeks.'}, {'measure': 'Change from Baseline in Depressive symptom severity using the Patient Health Questionnaire (PHQ-9), measured at 4 weeks and 8 weeks.', 'timeFrame': 'From enrollment (Baseline) to the end of treatment at 8 weeks.', 'description': 'The change in Depressive symptom severity will be measured using the Patient Health Questionnaire (PHQ-9), a validated 9-item questionnaire with scores ranging from 0 to 27, where higher scores indicate greater depressive symptom severity.\n\nChange in PHQ-9 will be measured between the intervention group and wait-list control group at baseline, 4 weeks, and 8 weeks.'}], 'secondaryOutcomes': [{'measure': 'Determine if intervention effectiveness differs by individual characteristics, considering in-group differences in baseline characteristics and clinical information.', 'timeFrame': 'From enrollment to the end of treatment at 8 weeks.', 'description': 'Multivariate regression analysis will be conducted to identify any independent association between baseline characteristics and changes in scores.\n\nThe equivalence of groups at baseline will be checked to control for differences if needed. Univariate descriptive statistics (distribution, measures of central tendency, and variability) will summarize baseline data.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Fertilization in Vitro', 'Reproductive Techniques, Assisted', 'Quality of Life', 'Psychological Well-Being', 'Yoga', 'Mind-Body Therapies', 'Complementary Therapies'], 'conditions': ['IVF', 'In Vitro Fertilization', 'Quality of Life (QOL)', 'Anxiety', 'Depression and Anxiety Symptom', 'Assisted Reproduction Technologies', 'Yoga', 'Mental Health']}, 'descriptionModule': {'briefSummary': 'The goal of this clinical trial is to learn if a four-week yoga program works to improve quality of life in people undergoing IVF (In Vitro Fertilization). It will also learn if a four-week yoga program decreases anxiety and depression symptoms in people undergoing IVF.\n\nThe main questions it aims to answer are:\n\n* Does a four-week yoga program effect quality of life, anxiety, and depression symptoms in people undergoing IVF?\n* Do the effects vary by individual characteristics of the people in the study?\n\nResearchers will compare the yoga intervention group to routine care as usual.\n\nParticipants will:\n\n* Participate in a weekly virtual yoga class for four weeks (total of four yoga classes), or follow routine care as usual while undergoing IVF.\n* Take three online surveys every 4 weeks.\n* Be involved in the study for 8 weeks.', 'detailedDescription': 'The lifetime prevalence of infertility globally is 17.5%, meaning that one in six people have experienced infertility at some point in their life.When unable to conceive, individuals and couples frequently turn to assisted reproductive technology services. Assisted reproductive technology (ART) treatments provide hope and reproductive opportunities to individuals and couples globally. Yet, ART treatments often cause emotional distress. The emotional and psychosocial distress that individuals undergoing ART care experience is comparable to the emotional experiences of women with cancer and other serious medical conditions. Substantial evidence illustrates the emotional burden of ART care and its negative impact on quality of life. In fact, this relentless emotional stress often causes women to stop ART treatments before achieving pregnancy, demonstrating that emotional factors do impact clinical outcomes.\n\nIndividuals in ART care have complex psychosocial needs along with biomedical ones. Because stress is so prominent in ART care and often contributes to discontinuing ART treatment, individuals may benefit from services aimed at reducing stress and anxiety and increasing quality of life. Psychosocial interventions, such as yoga, support the holistic needs of individuals in ART care. While previous studies and systematic reviews indicate that yoga for individuals in ART care is feasible, acceptable, and efficacious, there is a lack of rigorous studies on yoga interventions in ART care.\n\nTo address this critical need for health promotion and prevention of psychological distress, we will evaluate a four-week virtually delivered Hatha yoga intervention to support the psychosocial needs of individuals actively undergoing in vitro fertilization (IVF).\n\nIVF is the most common type of ART treatment in the US and globally. Yoga is a mind-body practice, rooted in ancient Indian philosophy, which positively impacts physical and mental health and well-being. Hatha yoga, which is commonly practiced in the United States, incorporates breathing exercises, postures, and meditation.\n\nA RCT with wait-list control group, using mixed effects analysis, will be conducted to achieve the following specific aims. 80 individuals actively undergoing IVF will be recruited for this study. Computer-generated block randomization will allocate 40 participants to the four-week virtually delivered Hatha yoga intervention group, and 40 participants will be allocated to the waitlist control group.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* 18 years of age or older\n* Understand English\n* Scheduled for or currently undergoing an IVF cycle\n* Access to smartphone/computer/tablet and internet\n* Have a valid working email address\n\nExclusion Criteria:\n\n* Individuals who are Pregnant, or who become Pregnant during the study\n* Individuals undergoing non-IVF cycles (i.e. intrauterine insemination)\n* Individuals undergoing a frozen embryo transfer (FET) cycle\n* Individuals who are currently regularly practicing yoga\n* Individuals who score in the "severe depression" classification on the PHQ-9 (PHQ-9 score of 20-27)\n* Individuals endorsing suicidal ideation (answering yes on #9 of PHQ-9).'}, 'identificationModule': {'nctId': 'NCT07415850', 'briefTitle': 'The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment', 'organization': {'class': 'OTHER', 'fullName': 'Villanova University'}, 'officialTitle': 'The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment: A Randomized Controlled Trial', 'orgStudyIdInfo': {'id': 'IRB-FY2026-6'}, 'secondaryIdInfos': [{'id': 'ASRM Nursing/PA Research Award', 'type': 'OTHER', 'domain': 'American Society for Reproductive Medicine (ASRM) Research Institute'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Intervention Group', 'description': 'After randomization, participants in this arm will receive the four-week yoga intervention.', 'interventionNames': ['Behavioral: Yoga']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Wait-List Control Group', 'description': 'After randomization, participants in this arm will receive routine care as usual for 4 weeks and then will receive the four-week yoga intervention.', 'interventionNames': ['Behavioral: Yoga']}], 'interventions': [{'name': 'Yoga', 'type': 'BEHAVIORAL', 'otherNames': ['Hatha yoga'], 'description': 'The intervention in this study is a four-week Hatha yoga intervention delivered virtually.', 'armGroupLabels': ['Intervention Group', 'Wait-List Control Group']}]}, 'contactsLocationsModule': {'locations': [{'zip': '19085', 'city': 'Villanova', 'state': 'Pennsylvania', 'country': 'United States', 'contacts': [{'name': 'Mary B Murray, MEd, BSN, RN', 'role': 'CONTACT', 'email': 'mmurra45@villanova.edu', 'phone': '4849955006'}], 'facility': 'Villanova University', 'geoPoint': {'lat': 40.03733, 'lon': -75.34908}}], 'centralContacts': [{'name': 'Mary Beth Murray, MEd, BSN, RN', 'role': 'CONTACT', 'email': 'mmurra45@villanova.edu', 'phone': '484-995-5006'}, {'name': 'Kimberly Trout, PhD, CNM, FACNM, FAAN', 'role': 'CONTACT', 'email': 'kimberly.trout@villanova.edu'}], 'overallOfficials': [{'name': 'Mary B Murray, MEd, BSN, RN', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Villanova University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO', 'description': 'Data will be de-identified and is not planned to be shared.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Villanova University', 'class': 'OTHER'}, 'collaborators': [{'name': 'American Society for Reproductive Medicine', 'class': 'UNKNOWN'}], 'responsibleParty': {'type': 'SPONSOR'}}}}